Abstract
Keywords
Apolipoproteins D Hyperthyroidism Hypothyroidism Thyroid Hormones Heart کمکاری تیروئید پرکاری تیروئید قلب آپولیپوپروتئین D هورمونهای تیرویید
References
-
1.
[1] Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler 2014; 26: 296-309.
-
2.
https://doi.org/10.1016/j.arteri.2014.07.003.
-
3.
PMid:25438971.
-
4.
[2] De K, Ghosh G, Datta M, Konar A, Bandyopadhyay J, Bandyopadhyay D, Bhattacharya S, Bandyopadhyay A. Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray. J Endocrinol 2004; 182: 303-314.
-
5.
https://doi.org/10.1677/joe.0.1820303.
-
6.
PMid:15283691.
-
7.
[3] Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116: 1725-1735.
-
8.
https://doi.org/10.1161/CIRCULATIONAHA.106.678326.
-
9.
PMid:17923583.
-
10.
[4] Stanciu AE, ZamfirChiruAnton A, Stanciu MM, Gheorghe DC. Impact of thyroid disease on heart failure. the role of the clinical cardiac electrophysiologist in the management of congestive heart failure 2017; 141.
-
11.
https://doi.org/10.5772/66283.
-
12.
[5] Elnakish MT, Ahmed AA, Mohler PJ, Janssen PM. Role of oxidative stress in thyroid hormone-induced cardiomyocyte hypertrophy and associated cardiac dysfunction: an undisclosed story. Oxid Med Cell Longev 2015; 2015: 854265.
-
13.
https://doi.org/10.1155/2015/854265.
-
14.
PMid:26146529 PMCid:PMC4471379.
-
15.
[6] Sabih DE, Inayatullah M. Managing thyroid dysfunction in selected special situations. Thyroid Res 2013; 6: 2.
-
16.
https://doi.org/10.1186/1756-6614-6-2.
-
17.
PMid:23379325 PMCid:PMC3626556.
-
18.
[7] Triggiani V, Iacoviello M, Monzani F, Puzzovivo A, Guida P, Forleo C, et al. Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone. Endocr Metab Immune Disord Drug Targets 2012; 12: 86-94.
-
19.
https://doi.org/10.2174/187153012799278947.
-
20.
PMid:22214334.
-
21.
[8] Mishra P, Samanta L. Oxidative stress and heart failure in altered thyroid states. ScientificWorldJournal 2012; 2012: 741861.
-
22.
https://doi.org/10.1100/2012/741861.
-
23.
PMid:22649319 PMCid:PMC3354657.
-
24.
[9] Mancini A, Di Segni C, Raimondo S, Olivieri G, Silvestrini A, Meucci E, Curr D. Thyroid hormones, oxidative stress, and inflammation. Mediators Inflamm 2016; 2016: 6757154.
-
25.
https://doi.org/10.1155/2016/6757154.
-
26.
PMid:27051079 PMCid:PMC4802023.
-
27.
[10] Fernandes R, Dreher G, Schenkel P, Fernandes T, Ribeiro M, Araujo A, BellKlein A. Redox status and prosurvival/proapoptotic protein expression in the early cardiac hypertrophy induced by experimental hyperthyroidism. Cell Biochem Funct 2011; 29: 617-623.
-
28.
https://doi.org/10.1002/cbf.1796.
-
29.
PMid:21989893.
-
30.
[11] Bergh JJ, Lin H-Y, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. Integrin V3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005; 146: 2864-2871.
-
31.
https://doi.org/10.1210/en.2005-0102.
-
32.
PMid:15802494.
-
33.
[12] Crespo-Sanjun J, Zamora-Gonzalez N, Calvo-Nieves MD, Andres-Ledesma C. Apolipoprotein D. Advances in Lipoprotein Research 2017: 25.
-
34.
https://doi.org/10.5772/66626.
-
35.
[13] Dassati S, Waldner A, Schweigreiter R. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging 2014; 35: 1632-1642.
-
36.
https://doi.org/10.1016/j.neurobiolaging.2014.01.148.
-
37.
PMid:24612673 PMCid:PMC3988949.
-
38.
[14] Martnez-Pinilla E, Navarro A, Ordez C, del Valle E, Tolivia J. Apolipoprotein D subcellular distribution pattern in neuronal cells during oxidative stress. Acta Histochemica 2015; 117: 536-544.
-
39.
https://doi.org/10.1016/j.acthis.2015.04.003.
-
40.
PMid:25953740.
-
41.
[15] Zhou Y, Wang L, Li R, Liu M, Li X, Su H, et al. Secreted glycoprotein BmApoD1 plays a critical role in anti-oxidation and anti-apoptosis in Bombyx mori. Biochem Biophys Res Commun 2018; 495: 839-845.
-
42.
https://doi.org/10.1016/j.bbrc.2017.11.044.
-
43.
PMid:29128356.
-
44.
[16] Bhatia S, Knoch B, Wong J, Kim WS, Else PL, Oakley AJ, Garner B. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease. Biochem J 2012; 442: 713-721.
-
45.
https://doi.org/10.1042/BJ20111166.
-
46.
PMid:22150111.
-
47.
[17] Leung WC, Lawrie A, Demaries S, Massaeli H, Burry A, Yablonsky S, et al. Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Circ Res 2004; 95: 179-186.
-
48.
https://doi.org/10.1161/01.RES.0000135482.74178.14.
-
49.
PMid:15192024.
-
50.
[18] Tsukamoto K, Mani D, Shi J, Zhang S, Haagensen DE, Otsuka F, et al. Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease. Proc Natl Acad Sci U S A 2013; 110: 17023-17028.
-
51.
https://doi.org/10.1073/pnas.1315986110.
-
52.
PMid:24082102 PMCid:PMC3801016.
-
53.
[19] Salami M, Bandegi AR, Sameni HR, Vafaei AA, Pakdel A. Hippocampal up-regulation of apolipoprotein D in a rat model of maternal hypo-and hyperthyroidism: implication of oxidative stress. Neurochem Res 2019; 44: 2190-2201.
-
54.
https://doi.org/10.1007/s11064-019-02859-5.
-
55.
PMid:31414343.
-
56.
[20] Martnez E, Navarro A, Ordnez C, del Valle E, Tolivia J. Oxidative stress induces apolipoprotein D overexpression in hippocampus during aging and Alzheimer's disease. J Alzheimers Dis 2013; 36: 129-144.
-
57.
https://doi.org/10.3233/JAD-130215.
-
58.
PMid:23568103.
-
59.
[21] Pascua Maestro R, Gonzlez E, Lillo C, Ganfornina MD, Falcon-Perez JM, Sanchez D. Extracellular vesicles secreted by astroglial cells transport Apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress. Front Cell Neurosci 2018; 12: 526.
-
60.
https://doi.org/10.3389/fncel.2018.00526.
-
61.
PMid:30687015 PMCid:PMC6335244.
-
62.
[22] Messarah M, Saoudi M, Boumendjel A, Boulakoud MS, El Feki A. Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart. Environ Toxicol Pharmacol 2011; 31: 33-41.
-
63.
https://doi.org/10.1016/j.etap.2010.09.003.
-
64.
PMid:21787667.
-
65.
[23] Oakley AJ, Bhatia S, Ecroyd H, Garner B. Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions: mechanism for selective oxidation of Met-93. PloS One 2012; 7: e34057.
-
66.
https://doi.org/10.1371/journal.pone.0034057.
-
67.
PMid:22479522 PMCid:PMC3316614.
-
68.
[24] Yao X, Sa R, Ye C, Zhang D, Zhang S, Xia H, et al. Effects of thyroid hormone status on metabolic pathways of arachidonic acid in mice and humans: a targeted metabolomic approach. Prostaglandins Other Lipid Mediat 2015; 118: 11-18.
-
69.
https://doi.org/10.1016/j.prostaglandins.2015.03.005.
-
70.
PMid:25841349.
-
71.
[25] Do Carmo S, Levros Jr L-C, Rassart E. Modulation of apolipoprotein D expression and translocation under specific stress conditions. Biochim Biophys Acta 2007; 1773: 954-969.
-
72.
https://doi.org/10.1016/j.bbamcr.2007.03.007.
-
73.
PMid:17477983.
-
74.
[26] Do Carmo S, Sguin D, Milne R, Rassart E. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 2002; 277: 5514-5523.
-
75.
https://doi.org/10.1074/jbc.M105057200.
-
76.
PMid:11711530.
-
77.
[1] Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler 2014; 26: 296-309.
-
78.
https://doi.org/10.1016/j.arteri.2014.07.003.
-
79.
PMid:25438971.
-
80.
[2] De K, Ghosh G, Datta M, Konar A, Bandyopadhyay J, Bandyopadhyay D, Bhattacharya S, Bandyopadhyay A. Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray. J Endocrinol 2004; 182: 303-314.
-
81.
https://doi.org/10.1677/joe.0.1820303.
-
82.
PMid:15283691.
-
83.
[3] Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116: 1725-1735.
-
84.
https://doi.org/10.1161/CIRCULATIONAHA.106.678326.
-
85.
PMid:17923583.
-
86.
[4] Stanciu AE, ZamfirChiruAnton A, Stanciu MM, Gheorghe DC. Impact of thyroid disease on heart failure. the role of the clinical cardiac electrophysiologist in the management of congestive heart failure 2017; 141.
-
87.
https://doi.org/10.5772/66283.
-
88.
[5] Elnakish MT, Ahmed AA, Mohler PJ, Janssen PM. Role of oxidative stress in thyroid hormone-induced cardiomyocyte hypertrophy and associated cardiac dysfunction: an undisclosed story. Oxid Med Cell Longev 2015; 2015: 854265.
-
89.
https://doi.org/10.1155/2015/854265.
-
90.
PMid:26146529 PMCid:PMC4471379.
-
91.
[6] Sabih DE, Inayatullah M. Managing thyroid dysfunction in selected special situations. Thyroid Res 2013; 6: 2.
-
92.
https://doi.org/10.1186/1756-6614-6-2.
-
93.
PMid:23379325 PMCid:PMC3626556.
-
94.
[7] Triggiani V, Iacoviello M, Monzani F, Puzzovivo A, Guida P, Forleo C, et al. Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone. Endocr Metab Immune Disord Drug Targets 2012; 12: 86-94.
-
95.
https://doi.org/10.2174/187153012799278947.
-
96.
PMid:22214334.
-
97.
[8] Mishra P, Samanta L. Oxidative stress and heart failure in altered thyroid states. ScientificWorldJournal 2012; 2012: 741861.
-
98.
https://doi.org/10.1100/2012/741861.
-
99.
PMid:22649319 PMCid:PMC3354657.
-
100.
[9] Mancini A, Di Segni C, Raimondo S, Olivieri G, Silvestrini A, Meucci E, Curr D. Thyroid hormones, oxidative stress, and inflammation. Mediators Inflamm 2016; 2016: 6757154.
-
101.
https://doi.org/10.1155/2016/6757154.
-
102.
PMid:27051079 PMCid:PMC4802023.
-
103.
[10] Fernandes R, Dreher G, Schenkel P, Fernandes T, Ribeiro M, Araujo A, BellKlein A. Redox status and prosurvival/proapoptotic protein expression in the early cardiac hypertrophy induced by experimental hyperthyroidism. Cell Biochem Funct 2011; 29: 617-623.
-
104.
https://doi.org/10.1002/cbf.1796.
-
105.
PMid:21989893.
-
106.
[11] Bergh JJ, Lin H-Y, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. Integrin V3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005; 146: 2864-2871.
-
107.
https://doi.org/10.1210/en.2005-0102.
-
108.
PMid:15802494.
-
109.
[12] Crespo-Sanjun J, Zamora-Gonzalez N, Calvo-Nieves MD, Andres-Ledesma C. Apolipoprotein D. Advances in Lipoprotein Research 2017: 25.
-
110.
https://doi.org/10.5772/66626.
-
111.
[13] Dassati S, Waldner A, Schweigreiter R. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging 2014; 35: 1632-1642.
-
112.
https://doi.org/10.1016/j.neurobiolaging.2014.01.148.
-
113.
PMid:24612673 PMCid:PMC3988949.
-
114.
[14] Martnez-Pinilla E, Navarro A, Ordez C, del Valle E, Tolivia J. Apolipoprotein D subcellular distribution pattern in neuronal cells during oxidative stress. Acta Histochemica 2015; 117: 536-544.
-
115.
https://doi.org/10.1016/j.acthis.2015.04.003.
-
116.
PMid:25953740.
-
117.
[15] Zhou Y, Wang L, Li R, Liu M, Li X, Su H, et al. Secreted glycoprotein BmApoD1 plays a critical role in anti-oxidation and anti-apoptosis in Bombyx mori. Biochem Biophys Res Commun 2018; 495: 839-845.
-
118.
https://doi.org/10.1016/j.bbrc.2017.11.044.
-
119.
PMid:29128356.
-
120.
[16] Bhatia S, Knoch B, Wong J, Kim WS, Else PL, Oakley AJ, Garner B. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease. Biochem J 2012; 442: 713-721.
-
121.
https://doi.org/10.1042/BJ20111166.
-
122.
PMid:22150111.
-
123.
[17] Leung WC, Lawrie A, Demaries S, Massaeli H, Burry A, Yablonsky S, et al. Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Circ Res 2004; 95: 179-186.
-
124.
https://doi.org/10.1161/01.RES.0000135482.74178.14.
-
125.
PMid:15192024.
-
126.
[18] Tsukamoto K, Mani D, Shi J, Zhang S, Haagensen DE, Otsuka F, et al. Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease. Proc Natl Acad Sci U S A 2013; 110: 17023-17028.
-
127.
https://doi.org/10.1073/pnas.1315986110.
-
128.
PMid:24082102 PMCid:PMC3801016.
-
129.
[19] Salami M, Bandegi AR, Sameni HR, Vafaei AA, Pakdel A. Hippocampal up-regulation of apolipoprotein D in a rat model of maternal hypo-and hyperthyroidism: implication of oxidative stress. Neurochem Res 2019; 44: 2190-2201.
-
130.
https://doi.org/10.1007/s11064-019-02859-5.
-
131.
PMid:31414343.
-
132.
[20] Martnez E, Navarro A, Ordnez C, del Valle E, Tolivia J. Oxidative stress induces apolipoprotein D overexpression in hippocampus during aging and Alzheimer's disease. J Alzheimers Dis 2013; 36: 129-144.
-
133.
https://doi.org/10.3233/JAD-130215.
-
134.
PMid:23568103.
-
135.
[21] Pascua Maestro R, Gonzlez E, Lillo C, Ganfornina MD, Falcon-Perez JM, Sanchez D. Extracellular vesicles secreted by astroglial cells transport Apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress. Front Cell Neurosci 2018; 12: 526.
-
136.
https://doi.org/10.3389/fncel.2018.00526.
-
137.
PMid:30687015 PMCid:PMC6335244.
-
138.
[22] Messarah M, Saoudi M, Boumendjel A, Boulakoud MS, El Feki A. Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart. Environ Toxicol Pharmacol 2011; 31: 33-41.
-
139.
https://doi.org/10.1016/j.etap.2010.09.003.
-
140.
PMid:21787667.
-
141.
[23] Oakley AJ, Bhatia S, Ecroyd H, Garner B. Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions: mechanism for selective oxidation of Met-93. PloS One 2012; 7: e34057.
-
142.
https://doi.org/10.1371/journal.pone.0034057.
-
143.
PMid:22479522 PMCid:PMC3316614.
-
144.
[24] Yao X, Sa R, Ye C, Zhang D, Zhang S, Xia H, et al. Effects of thyroid hormone status on metabolic pathways of arachidonic acid in mice and humans: a targeted metabolomic approach. Prostaglandins Other Lipid Mediat 2015; 118: 11-18.
-
145.
https://doi.org/10.1016/j.prostaglandins.2015.03.005.
-
146.
PMid:25841349.
-
147.
[25] Do Carmo S, Levros Jr L-C, Rassart E. Modulation of apolipoprotein D expression and translocation under specific stress conditions. Biochim Biophys Acta 2007; 1773: 954-969.
-
148.
https://doi.org/10.1016/j.bbamcr.2007.03.007.
-
149.
PMid:17477983.
-
150.
[26] Do Carmo S, Sguin D, Milne R, Rassart E. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 2002; 277: 5514-5523.
-
151.
https://doi.org/10.1074/jbc.M105057200.
-
152.
PMid:11711530.